Doxoark-M

Description

Key Ingredients:

Doxofylline 400 mg, Montelukast Sodium 10 mg

Product Info:~

Doxoark-M is a medication formulated with Doxofylline (400 mg) and Montelukast Sodium (10 mg) to provide effective relief from respiratory conditions and chronic obstructive pulmonary disease (COPD). Doxofylline, a bronchodilator, helps relax airway muscles and improve airflow, while Montelukast, a leukotriene receptor antagonist, reduces inflammation and checks bronchospasms. This combination ensures better breathing, reduces wheezing, and minimizes the risk of respiratory attacks. Doxoark-M is ideal for individuals seeking long-term respiratory health management.

Key Benefits:~ 

• Doxoark-M helps relieve bronchospasms and improves breathing.
• It reduces airway inflammation and checks respiratory attacks.
• It supports better lung function and airflow.
• It minimizes symptoms like wheezing, coughing, and shortness of breath.
• It helps in managing chronic respiratory conditions like COPD and other conditions.

We are a  pharmaceutical company catering to businesses only and offering innovative medicines to enhance healthcare ensuring high quality and effective solutions.